SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003723
Filing Date
2021-11-09
Accepted
2021-11-09 16:01:19
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scph-20210930.htm   iXBRL 10-Q 1975838
2 EX-31.1 scph-ex31_1.htm EX-31.1 16293
3 EX-32.1 scph-ex32_1.htm EX-32.1 12440
  Complete submission text file 0000950170-21-003723.txt   7668120

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scph-20210930_cal.xml EX-101.CAL 50463
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scph-20210930_lab.xml EX-101.LAB 398677
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scph-20210930_def.xml EX-101.DEF 138100
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scph-20210930.xsd EX-101.SCH 44474
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scph-20210930_pre.xml EX-101.PRE 290553
9 EXTRACTED XBRL INSTANCE DOCUMENT scph-20210930_htm.xml XML 1567105
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 211391931
SIC: 2834 Pharmaceutical Preparations